Agilon Health (NYSE:AGL) Stock Price Down 4.5% – Time to Sell?

Agilon Health, Inc. (NYSE:AGL) shares dropped 4.5% during trading on Wednesday . The company traded as low as $81.55 and last traded at $84.2750. Approximately 56,045 shares changed hands during mid-day trading, a decline of 85% from the average daily volume of 365,220 shares. The stock had previously closed at $88.20.

Analyst Ratings Changes

AGL has been the subject of a number of analyst reports. Deutsche Bank Aktiengesellschaft upgraded Agilon Health from a “hold” rating to a “buy” rating and upped their price objective for the stock from $33.00 to $49.00 in a research note on Thursday, May 7th. Wells Fargo & Company reissued an “overweight” rating and issued a $72.00 price objective (up from $37.50) on shares of Agilon Health in a report on Friday, May 8th. TD Cowen reissued a “hold” rating and issued a $55.00 price objective (up from $17.00) on shares of Agilon Health in a report on Monday, May 11th. Weiss Ratings upgraded Agilon Health from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Tuesday, May 12th. Finally, Citigroup restated a “neutral” rating and issued a $80.00 target price (up from $18.75) on shares of Agilon Health in a research note on Friday, May 15th. Five equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $52.50.

Agilon Health Stock Up 3.7%

The company has a market cap of $1.39 billion, a PE ratio of -3.85 and a beta of 2.29. The business has a 50-day simple moving average of $30.81 and a 200-day simple moving average of $21.93. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.08.

Agilon Health (NYSE:AGL) last announced its earnings results on Wednesday, May 6th. The company reported $1.80 EPS for the quarter, beating analysts’ consensus estimates of $1.04 by $0.76. The business had revenue of $1.42 billion during the quarter, compared to analysts’ expectations of $1.38 billion. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%. Equities research analysts anticipate that Agilon Health, Inc. will post -3.75 EPS for the current year.

Hedge Funds Weigh In On Agilon Health

Institutional investors have recently added to or reduced their stakes in the stock. Wealthcare Advisory Partners LLC acquired a new position in Agilon Health in the 3rd quarter valued at about $26,000. LPL Financial LLC increased its position in Agilon Health by 213.4% in the 4th quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock valued at $30,000 after acquiring an additional 30,000 shares during the period. Krilogy Financial LLC acquired a new position in Agilon Health in the 4th quarter valued at about $34,000. CIBC Bancorp USA Inc. acquired a new position in Agilon Health in the 3rd quarter valued at about $34,000. Finally, Merit Financial Group LLC acquired a new position in Agilon Health in the 4th quarter valued at about $35,000.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.